Newsletters
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
UK Pull (Netflix) pilot: QALY value of new antibiotics implies societal value > 10m GBP/year!
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), We’ve written before about the UK’s “Netflix” pilot antibiotic …
ICARS seeks Executive Director
Dear All, An interesting job listing for you today! The International Centre for Antimicrobial Resistance Solutions (ICARS) is looking for an …
Future Leaders Against AMR – Fireside Chat with Founder!
Dear All, As some of you may have seen on Twitter, the Future Leaders Against AMR have been busy! I …
Pull mechanisms: Private capital can multiply Subscription (Netflix) and TEV models!
Dear All: Three recent papers bring together an instructive perspective on Pull incentives for the #FireExtinguishersOfMedicine. The first two papers …
Comment on US 2023-2026 National Health Security Strategy
Dear All, The US Office of the Assistant Secretary for Preparedness & Response (ASPR) is looking for comments on the 2023-2026 National Health …
Implementation Handbook on National Action Plans from WHO
Dear All, Continuing on the theme of helping countries develop their own national action plans, WHO released the “WHO implementation …
Discussing Details of ATMF’s 2021 AMR Benchmark Report!
Dear All, As you may remember, last fall I wrote a newsletter about ATMF’s 3rd update to the AMR Benchmark …
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Dear All (wonkish alert: coffee up, settle in, and read the reports!), As you will recall, WHO’s most current pipeline …
Sign a letter in support of antifungal R&D … in support of PASTEUR!
Dear All: As you know if you are a regular reader of this newsletter, I think that creation of suitable Pull …
RFP: Gender inequality in AMR (with a focus on sub-Saharan Africa)
Dear All, Continuing with the theme of socio-economic inequality and AMR that we discussed in prior newsletters (31 Jan 2022, …
CC4CARB: (free!) rationally designed compound libraries based on your ideas!
Dear All, NIAID and RTI International have recently announced the initiation of CC4CARB Chemistry Center for Combating Antibiotic Resistance). In …
RFP: Climate-Sensitive Infectious Disease Modelling
Dear All, And now for something really different! With the recent GRAM report (20 Jan 2022 newsletter) showing that AMR is …
RFP: Support for creating Antimicrobial Stewardship Centers of Excellence
Dear All, I wrote in a 26 Oct 2021 newsletter about an RFP focused on Antimicrobial Stewardship (AMS) activities to address …
AlphaFold: Highly accurate protein structure prediction for WHO priority pathogens
Dear All, I learned today from our colleagues at WHO that Alphafold has recently added the proteome of nearly all the …
FORWARD Act, PREVENT Act, new NIAID RFP!
Dear All, Our US government colleagues have been busy! Three things back-to-back: First, the FORWARD Act (Finding Orphan-disease Remedies With Antifungal …
PAR Foundation grants: Early career support, prevention of AMR in the elderly
Dear All, The Stockholm-based PAR Foundation (aka, the Foundation to Prevent Antibiotic Resistance) has announced two groups of grant opportunities. First, …
#AMRSOS! GRAM report: “at least 1.27m deaths/year directly attributable to AMR”
Dear All, There are days when it is hard to keep up! Not only did we have the release today …
BARDA and NIAID RFPs addressing bacterial, fungal, and viral threats
Dear All, When it rains, it pours … and sometimes in a good way! Today saw the release of requests …
ARPEGE: New €17m French Consortium tackles economics, diagnostics, and therapeutics
Dear All, On 6 Jan 2022, we had the announcement of the creation of in France of the ARPEGE consortium …
WHO pipeline review; JPIAMR call on “Disrupting drug resistance using innovative design”
Dear All, First up, we have an update to WHO’s review of the clinical antibacterial pipeline. The review by Butler …
